Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Related Posts
Medanta Earning Growth: After a strong debut, can Medanta sustain gains? Earnings growth, retaining specialists will be key.
Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the…
weight loss: Planning a ‘skinny jab’? The truth behind miracle weight-loss drugs
Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Chengxi, Tan Chen, and Han Wei Liu Ping, a 25-year-old living in…
Mpox virus is back. Are India’s vaccine makers Serum Institute, Bharat Biotech ready?
Doctor holding blood sample for mpox virus test Synopsis The mpox virus that started from Central Africa has now reached…
